CFDE Data Portal | Search LINC01635

	Label	Description
	LINC01635 Gene (Entity type)	ENSG00000228397 - long intergenic non-protein coding RNA 1635
	GSE239844 crizotinib 6 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE209938 metformin PC 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 15 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE242333 sorafenib 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE155031 catechin SH-SY5Y 6 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx SmallIntestine 20-29 vs 30-39 Up Gene Set (Entity type)	A Gene Set from GTEx
	GSE149632 dopamine 7 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE153158 NF-kB knockout U-937 6 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE153158 NF-kB knockout U-937 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC01635

ENSG00000228397 - long intergenic non-protein coding RNA 1635

GSE239844 crizotinib 6 v 9 human up

A Gene Set from LINCS

GSE209938 metformin PC 0 v 1 human up

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 15 v 11 human dn

A Gene Set from LINCS

GSE242333 sorafenib 0 v 3 human up

A Gene Set from LINCS

GSE155031 catechin SH-SY5Y 6 v 0 human dn

A Gene Set from LINCS

GTEx SmallIntestine 20-29 vs 30-39 Up

A Gene Set from GTEx

GSE149632 dopamine 7 v 6 human dn

A Gene Set from LINCS

GSE153158 NF-kB knockout U-937 6 v 2 human up

A Gene Set from LINCS

GSE153158 NF-kB knockout U-937 1 v 2 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.